Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease

被引：27

作者：

Czartoryska, B

Tylki-Szymanska, A

Lugowska, A

机构：

[1] Inst Psychiat & Neurol, Dept Genet, PL-02957 Warsaw, Poland

[2] Childrens Mem Hlth Inst, Dept Metab Dis, Warsaw, Poland

来源：

CLINICAL BIOCHEMISTRY | 2000年 / 33卷 / 02期

关键词：

D O I：

10.1016/S0009-9120(99)00098-3

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：147 / 149

页数：3

共 10 条

[1] REPLACEMENT THERAPY FOR INHERITED ENZYME DEFICIENCY - MACROPHAGE-TARGETED GLUCOCEREBROSIDASE FOR GAUCHERS-DISEASE [J].

BARTON, NW ;

BRADY, RO ;

DAMBROSIA, JM ;

DIBISCEGLIE, AM ;

DOPPELT, SH ;

HILL, SC ;

MANKIN, HJ ;

MURRAY, GJ ;

PARKER, RI ;

ARGOFF, CE ;

GREWAL, RP ;

YU, KT .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) :1464-1470

[2]

Beutler E., 1995, METABOLIC MOL BASES, P2641

[3] Serum chitotriosidase activity in Gaucher patients on enzyme replacement therapy (ERT) [J].

Czartoryska, B ;

Tylki-Szymanska, A ;

Górska, D .

CLINICAL BIOCHEMISTRY, 1998, 31 (05) :417-420

[4] MARKED ELEVATION OF PLASMA CHITOTRIOSIDASE ACTIVITY - A NOVEL HALLMARK OF GAUCHER DISEASE [J].

HOLLAK, CEM ;

VANWEELY, S ;

VANOERS, MHJ ;

AERTS, JMFG .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1288-1292

[5] Therapeutic delivery of proteins to macrophages: Implications for treatment of Gaucher's disease [J].

Mistry, PK ;

Wraight, EP ;

Cox, TM .

LANCET, 1996, 348 (9041) :1555-1559

[6] A practical approach to diagnosis and management of Gaucher's disease [J].

Mistry, PK ;

Abrahamov, A .

BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (04) :817-840

[7] Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease [J].

Schiffmann, R ;

Heyes, MP ;

Aerts, JM ;

Dambrosia, JM ;

Patterson, MC ;

DeGraba, T ;

Parker, CC ;

Zirzow, GC ;

Oliver, K ;

Tedeschi, G ;

Brady, RO ;

Barton, NW ;

Nagineni, C ;

Kaneski, CR ;

Murray, GJ ;

Higgins, JJ ;

Tournay, A ;

Banerjee, TK ;

Kreps, C ;

Scott, LJC ;

McKee, MA ;

Crutchfield, K ;

Frei, K .

ANNALS OF NEUROLOGY, 1997, 42 (04) :613-621

[8] Enzyme replacement therapy in type III Gaucher disease [J].

Tylki-Szymanska, A ;

Czartoryska, B .

JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (02) :203-204

[9]

TylkiSzymanska A, 1996, EUR J HUM GENET, V4, P334

[10] Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase [J].

Young, E ;

Chatterton, C ;

Vellodi, A ;

Winchester, B .

JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (04) :595-602

← 1 →